PolyNovo Limited (FRA:MFJ)

Market Cap	381.83M -24.3%
Revenue (ttm)	90.74M +16.4%
Net Income	4.45M -44.4%
EPS	0.01 -44.4%
Shares Out	n/a
PE Ratio	79.69
Forward PE	57.43
Dividend	n/a
Ex-Dividend Date	n/a

Volume	590
Open	0.5250
Previous Close	0.5300
Day's Range	0.5250 - 0.5250
52-Week Range	0.4640 - 0.7700
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 19, 2026

About PolyNovo

PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, Hong Kong, and China. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn; NovoSorb MTX for burns, chronic, trauma, and surgical wounds; and hernia repair, plastics and reconstructive device products. The company was formerly known as Calzada Limited and changed ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 301
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: MFJ

Financial Performance

In fiscal year 2026, PolyNovo's revenue was 149.85 million, an increase of 16.43% compared to the previous year's 128.70 million. Earnings were 7.34 million, a decrease of -44.45%.

Financial numbers in AUD

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error